Welcome to our dedicated page for DOCUSIGN SEC filings (Ticker: DOCU), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on DOCUSIGN's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time SEC filing updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into DOCUSIGN's regulatory disclosures and financial reporting.
DocuSign, Inc. Chief Legal Officer James P. Shaughnessy reported open-market sales of company stock. On July 1, 2026, he sold a total of 12,000 shares of DocuSign common stock in two transactions under a pre-arranged Rule 10b5-1 trading plan.
One trade covered 11,754 shares at a reported price of $45.53 per share, and another covered 246 shares at $46.01 per share. Footnotes state the shares were actually sold in multiple trades at prices ranging from $44.95 to $45.92 and from $45.99 to $46.03, with full price-by-trade details available on request.
DocuSign, Inc. President and CEO Allan C. Thygesen reported selling a total of 26,250 shares of Common Stock in open-market transactions on July 1, 2026. The sales were executed in two tranches of 21,993 and 4,257 shares at prices ranging from $44.96 to $46.35 per share. The transactions were carried out under a pre-arranged Rule 10b5-1 trading plan, indicating they were scheduled in advance rather than timed discretionarily.
Morgan Stanley Smith Barney filed a Form 144 notice related to proposed sales of 6,000 shares of Common Stock tied to compensation awards. The filing lists 3,000 performance shares dated 06/10/2025 and 3,000 restricted stock dated 08/10/2025. The broker/dealer listed is Morgan Stanley Smith Barney LLC, and the securities are shown for trading on NASDAQ.
DocuSign, Inc. president and general manager of growth Robert Chatwani reported selling a total of 15,902 shares of common stock in open-market transactions. The sales, made under a pre-arranged Rule 10b5-1 trading plan, were executed at prices around the low-to-mid $40s per share, and he continues to hold 72,805 shares directly.
DOCUSIGN, INC. executive Robert Chatwani reported routine equity compensation activity. On June 15, 2026, he exercised awards that delivered 31,543 shares of common stock, primarily from restricted stock units and performance stock units converting into shares.
On the same date, 15,641 shares were withheld by the company to cover tax obligations from these vesting events, rather than being sold in the market. A prior entry shows an earlier grant of 346 shares of common stock on April 3, 2026 under the employee stock purchase plan.
Following these transactions, Chatwani directly holds 104,347 shares of DOCUSIGN common stock. The footnotes explain that RSUs and PSUs vest over several years based on continued service and, for PSUs, on subscription revenue and free cash flow performance targets.
DocuSign President and CEO Allan C. Thygesen reported routine equity compensation activity. On June 15, 2026, he exercised performance stock units and restricted stock units that each convert into one share of common stock, adding to his direct holdings.
As part of the same event, 32,510 shares of common stock were withheld by DocuSign to cover tax obligations triggered by the vesting of these awards, rather than being sold in the open market. Following these transactions, Thygesen directly owned 185,288 shares of common stock, reflecting compensation-related vesting and associated tax withholding, not discretionary buying or selling.